Published in Science on September 25, 1987
Precise localization of NF1 to 17q11.2 by balanced translocation. Am J Hum Genet (1989) 3.27
Comparison of filler DNA at immune, nonimmune, and oncogenic rearrangements suggests multiple mechanisms of formation. Mol Cell Biol (1989) 2.30
Identification of a new, abundant superfamily of mammalian LTR-transposons. Nucleic Acids Res (1993) 2.04
Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol (1989) 2.00
Fragile-X syndrome: unique genetics of the heritable unstable element. Am J Hum Genet (1992) 1.85
A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2. Hum Mol Genet (2003) 1.67
Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders. J Med Genet (1993) 1.37
Ultra-high resolution array painting facilitates breakpoint sequencing. J Med Genet (2006) 1.25
Common sequence motifs at the rearrangement sites of a constitutional X/autosome translocation and associated deletion. Am J Hum Genet (1992) 1.15
Prenatal identification of a girl with a t(X;4)(p21;q35) translocation: molecular characterisation, paternal origin, and association with muscular dystrophy. J Med Genet (1990) 1.09
Parental origin and timing of de novo Robertsonian translocation formation. Am J Hum Genet (2002) 1.06
Localization of DNA sequences to a region within Xp11.21 between incontinentia pigmenti (IP1) X-chromosomal translocation breakpoints. Am J Hum Genet (1991) 1.06
Asymmetry in chromosome pairing: a major factor in de novo mutation and the production of genetic disease in man. J Med Genet (1989) 1.02
Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. Proc Natl Acad Sci U S A (1993) 1.01
DNA interstrand cross-links promote chromosomal integration of a selected gene in human cells. Mol Cell Biol (1989) 1.00
Identification of sequence motifs at the breakpoint junctions in three t(1;9)(p36.3;q34) and delineation of mechanisms involved in generating balanced translocations. Hum Genet (2006) 0.99
X/Y translocations resulting from recombination between homologous sequences on Xp and Yq. Proc Natl Acad Sci U S A (1991) 0.97
Molecular analysis of X-autosome translocations in females with Duchenne muscular dystrophy. EMBO J (1991) 0.93
Sequence analysis of the breakpoint regions of an X;5 translocation in a female with Duchenne muscular dystrophy. Am J Hum Genet (1995) 0.87
Molecular analysis of a female Lesch-Nyhan patient. J Clin Invest (1989) 0.87
Quality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel. J Mol Diagn (2011) 0.86
Prenatal diagnosis of common genetic disorders. BMJ (1988) 0.75
Genetic anomalies in mammalian germ cells and their significance for human reproductive and developmental risk. Environ Health Perspect (1993) 0.75
Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet (1997) 4.29
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Variation among human 28S ribosomal RNA genes. Proc Natl Acad Sci U S A (1985) 4.04
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature (1986) 3.62
Differential stringent control of the tandem E. coli ribosomal RNA promoters from the rrnA operon expressed in vivo in multicopy plasmids. Cell (1983) 3.33
ASHG activities relative to education: Human genetics as a component of medical school curricula: A report to the American society of human genetics. Am J Hum Genet (1988) 3.24
Structure and variation of human ribosomal DNA: molecular analysis of cloned fragments. Gene (1981) 3.18
Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr (1986) 3.18
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat Genet (1995) 2.76
A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia. Anesthesiology (1991) 2.67
FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet (1998) 2.56
A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature (1987) 2.55
Physical separation of hemopoietic stem cells from cells forming colonies in culture. J Cell Physiol (1969) 2.46
Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron-microscopic cytochemical study. Muscle Nerve (1990) 2.41
10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys (2001) 2.30
Molecular analysis of cloned human 18S ribosomal DNA segments. Proc Natl Acad Sci U S A (1978) 2.29
Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet (1990) 2.20
Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature (1990) 2.20
Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet (1989) 2.12
Assignment of the gene for complete X-linked congenital stationary night blindness (CSNB1) to Xp11.3. Genomics (1989) 1.87
Chromosome stability in CHO cells. Somatic Cell Genet (1977) 1.86
Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. Science (1984) 1.85
Quantitation of human ribosomal DNA: hybridization of human DNA with ribosomal RNA for quantitation and fractionation. Pediatr Res (1973) 1.84
Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer (1997) 1.83
Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet (1992) 1.81
Segregation of recessive phenotypes in somatic cell hybrids: role of mitotic recombination, gene inactivation, and chromosome nondisjunction. Mol Cell Biol (1981) 1.80
A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics (1991) 1.77
Karyotyping. Methods Enzymol (1979) 1.75
Partial gene duplication as a cause of human disease. Hum Mutat (1992) 1.73
Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys (2000) 1.72
Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome. Hum Genet (1984) 1.64
Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol (1990) 1.64
Isolation of human cDNAs for asparagine synthetase and expression in Jensen rat sarcoma cells. Mol Cell Biol (1987) 1.61
Functional inactivation of bacteriophage lambda morphogenetic gene in RNA. Nature (1975) 1.60
Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet (2001) 1.58
Persistent chromosomal aberrations following radioiodine therapy for thyrotoxicosis. N Engl J Med (1966) 1.57
Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol (1989) 1.55
The role of glycosidically bound mannose in the assimilation of beta-galactosidase by generalized gangliosidosis fibroblasts. Biochem Biophys Res Commun (1976) 1.53
Age-related conversion of dystrophin-negative to -positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. J Neuropathol Exp Neurol (1990) 1.53
Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J (1991) 1.53
A polymorphism in the NPPA gene associates with asthma. Clin Exp Allergy (2008) 1.52
Holoprosencephaly in infants of diabetic mothers. J Pediatr (1983) 1.51
Partial gene duplication in Duchenne and Becker muscular dystrophies. J Med Genet (1988) 1.50
Linkage of genetic markers emt and chr in Chinese hamster cells. Somatic Cell Genet (1980) 1.49
Mapping of four translocation breakpoints within the Duchenne muscular dystrophy gene. Genomics (1989) 1.45
Postoperative irradiation for the prevention of heterotopic bone: analysis of different dose schedules and shielding considerations. Int J Radiat Oncol Biol Phys (1990) 1.42
Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet Cell Genet (1987) 1.40
The human 18S ribosomal RNA gene: evolution and stability. Am J Hum Genet (1986) 1.39
Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families. Genomics (1990) 1.38
Human ribosomal RNA genes: orientation of the tandem array and conservation of the 5' end. Science (1988) 1.38
Physical separation of hemopoietic stem cells differing in their capacity for self-renewal. J Exp Med (1969) 1.36
Direct-to-consumer genetic testing: good, bad or benign? Clin Genet (2009) 1.34
Complete sequence of the 43-kb human ribosomal DNA repeat: analysis of the intergenic spacer. Genomics (1995) 1.34
Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet (1993) 1.33
Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet (1991) 1.30
Localization of the mdx mutation within the mouse dystrophin gene. EMBO J (1988) 1.29
Evidence obtained by induced mutation frequency analysis for functional hemizygosity at the emt locus in CHO cells. Somatic Cell Genet (1979) 1.27
The secondary structure of human 28S rRNA: the structure and evolution of a mosaic rRNA gene. J Mol Evol (1987) 1.26
Sequence variations in the Boophilus microplus Bm86 locus and implications for immunoprotection in cattle vaccinated with this antigen. Exp Appl Acarol (1999) 1.26
HeLa cell identification by analysis of ribosomal DNA segment patterns generated by endonuclease restriction. Am J Hum Genet (1980) 1.23
The association of chromosome 3 duplication and the Cornelia de Lange syndrome. J Pediatr (1978) 1.21
Point mutation in the human dystrophin gene: identification through western blot analysis. Genomics (1991) 1.21
Human rDNA: evolutionary patterns within the genes and tandem arrays derived from multiple chromosomes. Genomics (2001) 1.20
Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth. Prenat Diagn (2010) 1.17
Evidence for mutation by unequal sister chromatid exchange in the Duchenne muscular dystrophy gene. Am J Hum Genet (1989) 1.17
Evidence for post-transcriptional control of the morphogenetic genes of bacteriophage lambda. J Mol Biol (1974) 1.17
Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl. Am J Hum Genet (1991) 1.17
The topographic organization of repetitive DNA in the human nucleolus. Genomics (1993) 1.17
Linkage analysis in X-linked ocular albinism. Genomics (1991) 1.17
Characterization and localization of the human genes for ribosomal ribonucleic acid. Pediatr Res (1977) 1.15
Chromosome loss is responsible for segregation at the HPRT locus in Chinese hamster cell hybrids. Somatic Cell Genet (1977) 1.15
Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics (1992) 1.13